{"transactions":[{"id":1389972,"issuer":{"id":86952,"kind":"organization","name":"BIONOMICS LTD/ADR","symbol":"BNOX"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2024-10-07T18:22:49.000Z","date":"2024-10-04","kind":"sale","planned":false,"acquired":false,"shares":557,"price":0.28,"value":155.96,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes Ordinary Shares represented by American Depositary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":93369060,"source":{"system":"sec-edgar","filing":"0000950170-24-113344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1194833/000095017024113344/ownership.xml","form_type":"4"}},{"id":1389971,"issuer":{"id":86952,"kind":"organization","name":"BIONOMICS LTD/ADR","symbol":"BNOX"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2024-10-07T18:22:49.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":180707,"price":0.29,"value":52405.03,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes Ordinary Shares represented by American Depositary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":93469320,"source":{"system":"sec-edgar","filing":"0000950170-24-113344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1194833/000095017024113344/ownership.xml","form_type":"4"}},{"id":1389970,"issuer":{"id":86952,"kind":"organization","name":"BIONOMICS LTD/ADR","symbol":"BNOX"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2024-10-07T18:22:49.000Z","date":"2024-10-02","kind":"sale","planned":false,"acquired":false,"shares":90806,"price":0.33,"value":29965.98,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes Ordinary Shares represented by American Depositary Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":125996580,"source":{"system":"sec-edgar","filing":"0000950170-24-113344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1194833/000095017024113344/ownership.xml","form_type":"4"}},{"id":1592189,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Series B Preferred Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":416665,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"In connection with the closing of the Issuer's initial public offering, each share of Series B Preferred automatically converted into common stock on a 2.1226069 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"In connection with the closing of the Issuer's initial public offering, each share of Series B Preferred automatically converted into common stock on a 2.1226069 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"In connection with the closing of the Issuer's initial public offering, each share of Series B Preferred automatically converted into common stock on a 2.1226069 for 1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}},{"id":1592188,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1063918,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":478359},"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}},{"id":1592187,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":406072,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are held by Apeiron Investment Group Ltd. (\"Apeiron\"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":182577},"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}},{"id":1592186,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Warrants to Purchase Series A Preferred Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":444561,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the closing of the Issuer's initial public offering, the Warrants were exercised on a cashless basis into shares of Series A Preferred Stock, which were automatically converted into shares of Common Stock on a 2.2241 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Issuer's initial public offering, the Warrants were exercised on a cashless basis into shares of Series A Preferred Stock, which were automatically converted into shares of Common Stock on a 2.2241 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the closing of the Issuer's initial public offering, the Warrants were exercised on a cashless basis into shares of Series A Preferred Stock, which were automatically converted into shares of Common Stock on a 2.2241 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the closing of the Issuer's initial public offering, the Warrants were exercised on a cashless basis into shares of Series A Preferred Stock, which were automatically converted into shares of Common Stock on a 2.2241 for 1 basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are held by Apeiron Investment Group Ltd. (\"Apeiron\"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":69304},"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}},{"id":1592185,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":674658,"ownership":{"direct":false,"nature":"By Apeiron Presight Capital Fund II, L.P.("},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reportable securities are held by Apeiron Presight Capital Fund II, L.P. (\"Apeiron Presight\"). Apeiron Investment Group Ltd. (\"Apeiron\") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. (\"Presight Management\"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities."}],"balance_after":674658,"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}},{"id":1592184,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":10106,"kind":"person","name":"Apeiron Investment Group Ltd.","position":1,"cik":"0001845711","reported_name":"Apeiron Investment Group Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":86953,"kind":"organization","name":"Apeiron Presight Capital Fund II, L.P.","position":2,"cik":"0001840676","reported_name":"Apeiron Presight Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":10108,"kind":"person","name":"Angermayer Christian","position":3,"cik":"0001845872","reported_name":"Angermayer Christian","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-06T14:15:59.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":251881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of Series A preferred stock automatically converted into common stock 2.2241 for 1 basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reportable securities are held by Apeiron Investment Group Ltd. (\"Apeiron\"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities."}],"balance_after":251881,"source":{"system":"sec-edgar","filing":"0000950170-24-026885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000095017024026885/ownership.xml","form_type":"4"}}]}